Oestrogen receptor β immunohistochemistry: Time to get it right?

Journal of Clinical Pathology

Volumn 61, Issue 10, 2008, Pages 1150-1151

  Speirs, V ^a,b   Green, C A ^a   Shaaban, A M ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; ESTROGEN RECEPTOR BETA 2; ESTROGEN RECEPTOR BETA 5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BREAST CANCER; BREAST CARCINOMA; CELLULAR DISTRIBUTION; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; WILD TYPE;

BREAST NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 53649106049     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Borgquist S, Holm C, Stendahl M, et al. Oestrogen receptors a and (5 show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. J Clin Pathol 2008;61:197-3.
2. Carder PJ, Murphy CE, Dervan P, et al. A multicentre investigation towards reaching a consensus on the immunohistochemical detection of ERp in archival formalin-fixed paraffin embedded human breast tissue. Breast Cancer Res Treat 2005;92:287-93.
3. Shaaban AM, Speirs V. Estrogen receptor β-which one and where should we draw the line? Hum Pathol 2006;37:498.
4. Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and characterization of human estrogen receptorβ isoforms. Biochem Biophys Res Commun 1998;247:75.
5. Poola I, Abraham J, Baldwin K, et al. Estrogen receptors β4 and β5 are full length functionally distinct ERβ isoforms: cloning from human ovary and functional characterization. Endocrine 2005;27:227-38.
6. Skliris GP, Parkes AT, Limer JL, et al. Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 2002;197:155-62.
7. Weitsman GE, Skliris G, Ung K, et al. Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res Treat 2006;100:23-31.
8. Shaaban AM, Green AR, Karthik S, et al. Nuclear and cytoplasmic expression of ERβ1, -2 and -5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res. In press. doi: 10.1158/1078-0432.CCR-07-4528.
9. Rees ML, Marshall I; Mclntosh GG, et al. Wild-type estrogen receptor β expression in normal and neoplastic paraffin-embedded tissues. Hybrid Hybridomics 2004;23:11.
10. Saunders PT, Millar MR, Williams K, et al. Expression of oestrogen receptor β (ERβ1) protein in human breast cancer biopsies. Br J Cancer 2002;86:250-6.
11. Shaaban AM, O'Neill PA, Davies MP, et al. Declining estrogen receptor-β expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 2003;27:1502-12.
12. Fuqua SA, Schiff R, Parra I, et al. Estrogen receptor β protein in human breast cancer: correlation with clinical tumour parameters. Cancer Res 2003;63:2343-39.
13. Nakopoulou L, Lazaris AC, Panayotopoulou, et al. The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer. J Clin Pathol 2004;57:523-8.